MASLD is now one of the most common liver diseases in the world, affecting an estimated 1 in 4 adults globally. Many patients remain undiagnosed until significant liver damage has already occurred.

Through education, patient empowerment, and healthcare advocacy, we work to ensure
* earlier diagnosis
* improved access to care
* patient-centered treatment
* greater awareness of liver health